Intravenous Glutamine Administration Improves Glucose Tolerance and Attenuates the Inflammatory Response in Diet-Induced Obese Mice after Sleeve Gastrectomy
Open Access
- 19 October 2020
- Vol. 12 (10), 3192
- https://doi.org/10.3390/nu12103192
Abstract
Obesity is a health problem associated with many metabolic disorders. Weight reduction can effectively alleviate obesity-associated complications. Sleeve gastrectomy is a commonly used bariatric surgery and is considered safe and effective for improving outcomes. Glutamine (GLN) is an amino acid with anti-oxidative and anti-inflammatory properties. This study used a mouse model of sleeve gastrectomy to investigate the impacts of intravenous GLN administration on glucose tolerance and adipocyte inflammation short-term after surgery. C57BL6 male mice were divided into normal control (NC) and high-fat diet groups. The high-fat diet provided 60% of energy from fat for 10 weeks to induce obesity. Mice fed the high-fat diet were then assigned to a sham (SH) or sleeve gastrectomy with saline (S) or GLN (G) groups. The S group was intravenously injected with saline, while the G group was administered GLN (0.75 g/kg body weight) via a tail vein postoperatively. Mice in the experimental groups were sacrificed on day 1 or 3 after the surgery. Results showed that obesity resulted in fat accumulation, elevated glucose levels, and adipokines production. Sleeve gastrectomy aggravated expressions of inflammatory cytokine and macrophage infiltration markers, cluster of differentiation 68 (CD68), epidermal growth factor-like module-containing mucin-like hormone receptor-like 1 (EMR-1), and macrophage chemoattractant protein-1, in adipose tissues. Treatment of obese mice with GLN downregulated hepatic proteomic profiles associated with the gluconeogenesis pathway and improved glucose tolerance. Moreover, macrophage infiltration and adipose tissue inflammation were attenuated after the sleeve gastrectomy. These findings imply that postoperative intravenous GLN administration may improve glucose tolerance and attenuate inflammation shortly after the bariatric surgery in subjects with obesity.This publication has 34 references indexed in Scilit:
- A complications-based clinical staging of obesity to guide treatment modality and intensityCurrent Opinion in Endocrinology, Diabetes and Obesity, 2013
- Sleeve Gastrectomy as a Stand-alone Bariatric Operation for Severe, Morbid, and Super ObesityJSLS : Journal of the Society of Laparoendoscopic Surgeons, 2013
- Health Evaluation of Experimental Laboratory MiceCurrent Protocols in Mouse Biology, 2012
- Effects of glutamine supplementation on oxidative stress-related gene expression and antioxidant properties in rats with streptozotocin-induced type 2 diabetesBritish Journal of Nutrition, 2011
- Health-related Quality of Life in Adult Patients with Morbid Obesity Coming for Bariatric SurgeryObesity Surgery, 2008
- Overweight, Obesity, and Mortality in a Large Prospective Cohort of Persons 50 to 71 Years OldThe New England Journal of Medicine, 2006
- Prevention Conference VIIJournal of the American College of Cardiology, 2004
- Inflammatory pathways and insulin actionInternational Journal of Obesity, 2003
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- F4/80, a monoclonal antibody directed specifically against the mouse macrophageEuropean Journal of Immunology, 1981